Temsirolimus, sold under the brand name Torisel, is an intravenous drug for the treatment of renal cell carcinoma, developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration in May 2007, and was also approved by the European Medicines Agency in November 2007. Wikipedia